Company profile for twoXAR Pharmaceutical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

twoXAR is an artificial intelligence-driven drug discovery company. The company leverages its computational platform to identify promising drug candidates, de-risks the opportunities through preclinical studies, and progresses drug candidates to the clinic through industry and investor partnerships.The convergence of big data, cloud computing, and artificial intelligence has allowed twoXAR to build a drug discovery platform th...
twoXAR is an artificial intelligence-driven drug discovery company. The company leverages its computational platform to identify promising drug candidates, de-risks the opportunities through preclinical studies, and progresses drug candidates to the clinic through industry and investor partnerships.The convergence of big data, cloud computing, and artificial intelligence has allowed twoXAR to build a drug discovery platform that is orders of magnitude faster, cheaper, and more accurate than traditional approaches. twoXAR leverages its technology internally to build its own pipeline of therapeutic candidates across diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
883 N. Shoreline Blvd, Suite A100, Mountain View, CA 940
Telephone
Telephone
(650) 382-2605
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/twoxar-pharmaceuticals-presents-preclinical-data-demonstrating-positive-safety-and-tolerability-of-two-novel-nash-treatment-candidates-301172425.html

PRNEWSWIRE
13 Nov 2020

https://www.prnewswire.com/news-releases/twoxar-pharmaceuticals-presents-positive-preclinical-safety-and-efficacy-data-for-its-novel-investigational-cancer-treatment-txr-311-301080554.html

PRNEWSWIRE
22 Jun 2020

https://www.prnewswire.com/news-releases/1st-biotherapeutics-and-twoxar-advance-three-novel-glioblastoma-treatment-candidates-into-in-vivo-testing-in-less-than-one-year-301010327.html

PR NEWSWIRE
25 Feb 2020

https://www.businesswire.com/news/home/20190417005997/en/SK-Biopharmaceuticals-twoXAR-Sign-Collaboration-Agreement-Discover

BusinessWire
17 Apr 2019

https://www.businesswire.com/news/home/20190103005006/en

BUSINESSWIRE
03 Jan 2019

https://venturebeat.com/2018/03/19/twoxar-raises-10-million-from-softbank-andreessen-horowitz-and-os-fund-to-grow-its-ai-drug-discovery-platform/

VENTURE BEAT
19 Mar 2018

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty